<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><description>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。目前拥有七项数据分析技术获国家专利，每月收集数据3000多万条，有63个专业数据库为医药健康行业服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 27 Jan 2021 20:42:09 +0800</pubDate><image><url>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</url><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>142家药企晒2020成绩单！九州通、长春高新……净利润超30亿，41家翻倍，这5家续亏</title><link>https://mp.weixin.qq.com/s/Bv9xF6N-s0JA3fcjtYzIlA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrvLlr8ms4zpoNXkEBl8FuJ2Ey2RBpoa5cqyCgHpC1KNklk3Y1qTFdgpiaUHbau84IJCxzYPtN9twibg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>超6成企业预喜]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:56:18 +0800</pubDate></item><item><title>【瞩目】30亿注射剂大品种！海思科过评了，石药、豪森等蜂拥而至</title><link>https://mp.weixin.qq.com/s/Fq1IspheT0ij3RnqR7tOiw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrvLlr8ms4zpoNXkEBl8FuJ2Tk4AeFaNDaMnl19KPAztssa8ZVpQyxJBJEFXhiaY65g7alpprSX2LoA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>补充申请获批]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:56:18 +0800</pubDate></item><item><title>【关注】北京药企抢首仿！阿斯利康4亿口服降糖药受冲击</title><link>https://mp.weixin.qq.com/s/Yd1DE0UXsjYLjcITKc21Uw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrvLlr8ms4zpoNXkEBl8FuJ2ENDY0zMReK7NFpTZMicCMRE5lMibMvicHaTZLicJHzTXeficTyCUvKc5ndw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>仿制4类报产]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:56:18 +0800</pubDate></item><item><title>【获批】6亿心血管药“激战”！3家药企同日过评</title><link>https://mp.weixin.qq.com/s/InPtoRQzDDPny1TEe-NgcA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrvLlr8ms4zpoNXkEBl8FuJ2Q0WDo61phEAaLztTGL2QrgKzPibdWhRlbKocLTd7zicSprgeYu83lNTQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>13家过评]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:56:18 +0800</pubDate></item><item><title>科伦开挂了！拿下15个重磅品种，36个过评品种亮眼，11款1类新药、41个新品在路上</title><link>https://mp.weixin.qq.com/s/_QEs4TI8L7AGbRq4y2HSqw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrteLYWxJibUaD3Age9fkrhkyGEGOoF0O8tcfOpo2YkGf5AWN724viczgnquyJcj1FTiaZXVZxGxhTvVQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>4款新品待批]]></content:encoded><pubDate>Tue, 26 Jan 2021 16:05:31 +0800</pubDate></item><item><title>【瞩目】东阳光药将拿下$120亿明星抗凝药</title><link>https://mp.weixin.qq.com/s/l73K5G8PZBlp-x_Sjbb2OA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrteLYWxJibUaD3Age9fkrhky48NIHCjfXGJKFQEZ4Fm6cPJ2URh5Ujic4L4t76iaRQWSTgmaBicPcwOSw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>多家药企布局]]></content:encoded><pubDate>Tue, 26 Jan 2021 16:05:31 +0800</pubDate></item><item><title>【市场】常用抗痛风药！首家过评企业来了</title><link>https://mp.weixin.qq.com/s/BX579RQkq9Prrdni8IqdSw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrteLYWxJibUaD3Age9fkrhkypkFbV2Pk9tuSs74scUAC2gqApBQQIrEGM8sib3gyFBChibQicDibxy9eeg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医保甲类品种]]></content:encoded><pubDate>Tue, 26 Jan 2021 16:05:31 +0800</pubDate></item><item><title>【干货】石药集团支招！缩短研发周期，降低研发成本</title><link>https://mp.weixin.qq.com/s/XENx7eLWrkpSWzdWgTGBOA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrteLYWxJibUaD3Age9fkrhky9aUTfYiaMKdGwRd0hzg6XQwjKjKMhbWTZGxgm5tRiba43BgrKemxIKsg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>深度剖析]]></content:encoded><pubDate>Tue, 26 Jan 2021 16:05:31 +0800</pubDate></item><item><title>“一哥”易主，药店TOP20洗牌！3大品种大涨，慢病药“霸屏”，正大天晴“崛起”</title><link>https://mp.weixin.qq.com/s/k5zKNluLlq-qAoMM1CoasA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrvsKulJ806fFVn57v2xgcQOicNEBkBGiczHl771YPYlrAzyT2K40gYjmwqnXr1z4eLqibentqeYlKIwg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>市场规模首超500亿]]></content:encoded><pubDate>Mon, 25 Jan 2021 16:03:55 +0800</pubDate></item><item><title>【重磅】超35亿大品种扬子江批了，龙头地位稳如泰山</title><link>https://mp.weixin.qq.com/s/lvC1JhtRYP13xLZqvXbN7A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrvsKulJ806fFVn57v2xgcQO4sGSaAvm3ZTVsIVibeFIEDwpuPEDokhibm4BbgI8SPtXBibGCG9BRtWXQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>市场份额攀升]]></content:encoded><pubDate>Mon, 25 Jan 2021 16:03:55 +0800</pubDate></item><item><title>【瞩目】奥赛康发力，重磅注射剂首家过评</title><link>https://mp.weixin.qq.com/s/Gk9rvt4mzKWbwWQw0y_J2A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrvsKulJ806fFVn57v2xgcQOdTb4NkkS5feVmMsql7XPOYgxEQY88IpDarxnsYo0StYkXMicEzkOdUQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>巩固市场]]></content:encoded><pubDate>Mon, 25 Jan 2021 16:03:55 +0800</pubDate></item><item><title>【聚焦】正大天晴将拿下超$30亿品种，与豪森、科伦围攻原研药</title><link>https://mp.weixin.qq.com/s/h4k4vsJ9UcuoHYrvndLNiA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrvsKulJ806fFVn57v2xgcQO8ERZR6F7ibdJfojbVkdtPbwBvPkwGIy9yg8IMKemFDHjzFLyfnvH3fA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>冲刺国产第3家]]></content:encoded><pubDate>Mon, 25 Jan 2021 16:03:55 +0800</pubDate></item><item><title>扬子江、先声、恒瑞......41个新药获批临床！590亿降压市场新药来袭，百济神州PD-1亮了</title><link>https://mp.weixin.qq.com/s/X-DdTpadTjISVR9yNxkH2A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/WGnrvqgA7n5hGJ48eicUCCkXT2XodA2LOszMHbMTU4WyDvkmLia3lO0MKVZ8CTCicbTQ191na9aWIF6ic4yrbb2Djw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>新药审评报告]]></content:encoded><pubDate>Sun, 24 Jan 2021 07:54:42 +0800</pubDate></item><item><title>4个注射剂被调查，招投标、开单提成……中纪委再掀反腐风暴！片仔癀、同仁堂登胡润品牌榜</title><link>https://mp.weixin.qq.com/s/PcAmzGohr511HXRr6buMJw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExruPfgeG8ibCEc5dGal1TLga8vMRibdsibqTlD5dicfqBXqbFOkxV5EyRl6t7BaNqLpMCvBA3jqvrkBSlg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药行业一周大事件]]></content:encoded><pubDate>Sat, 23 Jan 2021 08:21:17 +0800</pubDate></item><item><title>国采品种暴涨131%，华海净利润首冲10亿！8大新品获批，1类新药冲击千亿市场</title><link>https://mp.weixin.qq.com/s/dONzWnN0rnLzmkL5jLSwqA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExruPfgeG8ibCEc5dGal1TLga89r1wG99KgLaMGofibcfXx5XGC1qYXOYkofglqYJ66DuiazXkaAdAprfQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>一体化龙头向仿创升级]]></content:encoded><pubDate>Fri, 22 Jan 2021 16:39:00 +0800</pubDate></item><item><title>【重磅】海思科又爆发！麻醉剂国产第二家、超10亿抗血栓药将获批</title><link>https://mp.weixin.qq.com/s/0Nv_6eshkajfDEOZmJIOTQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExruPfgeG8ibCEc5dGal1TLga8Ss1jneUXia28bYRZWHYme5lEA7kG0P4vdbqBn74vhYRcYcxKr7ECINg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>麻醉剂新品频出]]></content:encoded><pubDate>Fri, 22 Jan 2021 16:39:00 +0800</pubDate></item><item><title>【焦点】丽珠微球已成10亿产品，新药来袭瞄准这个领域</title><link>https://mp.weixin.qq.com/s/qhvgKm07tL0Pvc4fhBTzdA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExruPfgeG8ibCEc5dGal1TLga8fuIo95acL9aEHdJF8ofh0Ow9qTCGu63LIpiaOo070iaSgMW4YYG1YDkA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>已有四个微球新品获批临床]]></content:encoded><pubDate>Fri, 22 Jan 2021 16:39:00 +0800</pubDate></item><item><title>【瞩目】成都药企争首仿！医保谈判“带飞”原研药销售飙升</title><link>https://mp.weixin.qq.com/s/8WadSFo68f_xwqekVbU9Tw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExruPfgeG8ibCEc5dGal1TLga8zxM25GiaM3vRzn8U16CmbpJ5awAOGfSmPy5VDZGx34iaCp3DichyjoO5Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>恒瑞、天晴4类仿制在审]]></content:encoded><pubDate>Fri, 22 Jan 2021 16:39:00 +0800</pubDate></item><item><title>神经系统化药TOP10出炉！扬子江、人福……8大注射剂“霸屏”，恒瑞独家产品亮眼</title><link>https://mp.weixin.qq.com/s/sdnJMeXxio4OJfPGbEF66Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrvq788xC63nQt1Qcib8S60XM3ICRG2W75QvWFvdn3gN5iar5WmGODG10w8FuEWVzuic9joeEZX9o6JZA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>四大亚类合揽八成市场]]></content:encoded><pubDate>Thu, 21 Jan 2021 16:45:12 +0800</pubDate></item><item><title>【瞩目】正大天晴“抢食”10亿抗肿瘤注射剂！国药、亿腾8家紧跟而至</title><link>https://mp.weixin.qq.com/s/N9MbHadmgcUdmtalnLMkCQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/HKOy4YsExrvq788xC63nQt1Qcib8S60XMLhxBgyB0icmEibNib8Ow1HlnibGK5uCWE09UdOo5xmsONuzKGC6f7Ua4AA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>5家企业过评]]></content:encoded><pubDate>Thu, 21 Jan 2021 16:45:12 +0800</pubDate></item></channel></rss>